Affiliation:
1. Regional Clinical Hospital No. 3
2. South Ural State Medical University
3. South Ural State University
4. Linline Clinic LLC
Abstract
Introduction. External manifestations of aging, and especially skin aging are the most important for modern women.Aim. The aim of our study was to identify a set of adverse factors that effect on the skin of women in menopausal transition (MP) and in postmenopause (PM), and to identify markers of skin aging in this category of women.Materials and methods. The study included 36 women in MP and PM suffering from MS. At the first stage, anamnesis was collected, anthropometric data and severity of MS were evaluated, and the hormonal profile of patients was determined. At the second stage, computer mapping of the skin was performed using the digital video camera Aramo SG with the skin XPpro program. Statistic analysis was performed using the SPSS v13.0 program. Spearman’s analysis was used to determine the relationship between anthropometric, clinical and anamnestic data and the measurements of skin condition of women in MP and PM. Results. According to the obtained data, the main triggers of skin aging of women in MP and PM are: the presence of metabolic disorders (obesity, metabolic syndrome), decrease of estradiol and progesterone levels in blood serum as well as increase of prolactin level and rhythm disturbance of melatonin secretion. Markers of skin aging in women with menopausal syndrome are decreased moisture, increased oiliness in T-zone, increased of skin pigmentation and enlarged pore size.Conclusions. The obtained data are useful for management involuting skin changes of women in PM and MP suffering from MS. The data justifies the relevancy to normalization not only the estradiol level, but other sex steroids, melatonin, as well as correction of metabolic endocrine processes, and treatment of MS.
Reference31 articles.
1. Cintron D., Lipford M., Larrea-Mantilla L., Spencer-Bonilla G., Lloyd R., Gionfriddo M.R. et al. Efficacy of menopausal hormone therapy on sleep quality: systematic review and meta-analysis. Endocrine. 2017;55(3):702–711. https://doi.org/10.1007/s12020-016-1072-9.
2. Smetnik V.P. Medicine Menopause. Jaroslavl: Litera; 2006. 848 p. (In Russ.) Available at: https://elibrary.ru/item.asp?id=19535785.
3. Dalle C. (ed.). The Guide. Global Aging Management. Margeride; 2010. Vol. 1. 496 р.
4. Usoltseva E.N., Solovyev A.G., Mamontova A.G. Perimenopausal melatonin deficiency syndrome in the system of personalized quality of life management in women with pathological menopause. Uspekhi gerontologii = Advances in Gerontology. 2019;32(4):516–523. (In Russ.) Available at: https://elibrary.ru/item.asp?id=39541877.
5. Boza J.C., Trindade E.N., Peruzzo J., Sachett L., Rech L., Cestari T.F. Skin manifestations of obesity: a comparative study. J Eur Acad Dermatol Venereol. 2012;26(10):1220–1223. https://doi.org/10.1111/j.1468-3083.2011.04265.x.